{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:07:07Z","timestamp":1792271227395,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.kint.2017.01.010","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T09:47:50Z","timestamp":1489571270000},"page":"140-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury"],"prefix":"10.1016","volume":"92","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongshun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.01.010_bib1","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diacare.27.2007.S79","article-title":"Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2017.01.010_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","article-title":"End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions","volume":"34","author":"Ritz","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.01.010_bib3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.01.010_bib4","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","article-title":"From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy","volume":"54","author":"Wolf","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2017.01.010_bib5","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1172\/JCI57935","article-title":"The targeted podocyte","volume":"121","author":"Fogo","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2017.01.010_bib6","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1038\/sj.ki.5002384","article-title":"Podocyte biology in diabetic nephropathy","volume":"106","author":"Li","year":"2007","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2017.01.010_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ki.2010.335","article-title":"Beyond genetics: epigenetic code in chronic kidney disease","volume":"79","author":"Dwivedi","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.01.010_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nm.2135","article-title":"Methylation determines fibroblast activation and fibrogenesis in the kidney","volume":"16","author":"Bechtel","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2017.01.010_bib9","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2010111196","article-title":"Valproic acid attenuates proteinuria and kidney injury","volume":"22","author":"Van Beneden","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.01.010_bib10","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1681\/ASN.2010060633","article-title":"Epigenetic histone methylation modulates fibrotic gene expression","volume":"21","author":"Sun","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.01.010_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000324944","article-title":"Epigenetic mechanisms","volume":"170","author":"Villeneuve","year":"2011","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2017.01.010_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.kint.2017.01.010_bib13","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1038\/sj.onc.1204341","article-title":"DNA methylation, methyltransferases, and cancer","volume":"20","author":"Robertson","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.kint.2017.01.010_bib14","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1681\/ASN.2011060629","article-title":"Epigenetics in diabetic kidney disease","volume":"22","author":"Reddy","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.01.010_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ki.2015.148","article-title":"Recent developments in epigenetics of acute and chronic kidney diseases","volume":"88","author":"Reddy","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.01.010_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrneph.2010.55","article-title":"Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms","volume":"6","author":"Tonna","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2017.01.010_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1755-8794-3-33","article-title":"Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus","volume":"3","author":"Bell","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.kint.2017.01.010_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/epi.6.1.13362","article-title":"DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy","volume":"6","author":"Sapienza","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.kint.2017.01.010_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/15680096113139990077","article-title":"DNA methyltransferase inhibitors as epigenetic therapy for cancer","volume":"13","author":"Singh","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.kint.2017.01.010_bib20","first-page":"166","article-title":"Evolution of renal function abnormalities in the db\/db mouse that parallels the development of human diabetic nephropathy","volume":"4","author":"Cohen","year":"1996","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.kint.2017.01.010_bib21","doi-asserted-by":"crossref","first-page":"F301","DOI":"10.1152\/ajprenal.00607.2010","article-title":"Recent insights into diabetic renal injury from the db\/db mouse model of type 2 diabetic nephropathy","volume":"300","author":"Tesch","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2017.01.010_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ki.2015.331","article-title":"Kallistatin protects against diabetic nephropathy in db\/db mice by suppressing AGE-RAGE-induced oxidative stress","volume":"89","author":"Yiu","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.01.010_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ki.2013.387","article-title":"Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db\/db mice","volume":"85","author":"Reddy","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.01.010_bib24","doi-asserted-by":"crossref","first-page":"18736","DOI":"10.1074\/jbc.M114.563650","article-title":"The epigenetic drug 5-azacytidine interferes with cholesterol and lipid metabolism","volume":"289","author":"Poirier","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2017.01.010_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ng1068","article-title":"DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells","volume":"33","author":"Robert","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2017.01.010_bib26","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1093\/carcin\/bgm206","article-title":"Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state","volume":"28","author":"Kanai","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.kint.2017.01.010_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2017.01.010_bib28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0378-1119(99)00357-1","article-title":"The Sp-family of transcription factors","volume":"238","author":"Suske","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.kint.2017.01.010_bib29","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2007-08-110171","article-title":"Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1\/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia","volume":"111","author":"Liu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.kint.2017.01.010_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2199-10-83","article-title":"Regulation of Neph3 gene in podocytes-key roles of transcription factors NF-kappaB and Sp1","volume":"10","author":"Ristola","year":"2009","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.kint.2017.01.010_bib31","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1128\/MCB.18.3.1266","article-title":"Functional interference of Sp1 and NF-kappaB through the same DNA binding site","volume":"18","author":"Hirano","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.kint.2017.01.010_bib32","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/j.1460-2075.1993.tb06029.x","article-title":"A\u00a0cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation","volume":"12","author":"Perkins","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/j.kint.2017.01.010_bib33","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1074\/jbc.272.5.2901","article-title":"Sp1 is a critical regulator of the Wilms' tumor-1 gene","volume":"272","author":"Cohen","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2017.01.010_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2199-7-17","article-title":"Role of transcription factor Sp1 and CpG methylation on the regulation of the human podocalyxin gene promoter","volume":"7","author":"Butta","year":"2006","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.kint.2017.01.010_bib35","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/ndt\/gfq750","article-title":"Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production","volume":"26","author":"Toyonaga","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.01.010_bib36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/bph.12292","article-title":"NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db\/db mice","volume":"170","author":"Zhang","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.kint.2017.01.010_bib37","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2337\/db12-1504","article-title":"Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury","volume":"62","author":"Eid","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2017.01.010_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/excr.1997.3739","article-title":"Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines","volume":"236","author":"Mundel","year":"1997","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.kint.2017.01.010_bib39","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.yexcr.2013.01.007","article-title":"NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression","volume":"319","author":"Li","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.kint.2017.01.010_bib40","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1152\/ajprenal.90642.2008","article-title":"The monocyte chemoattractant protein-1\/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability","volume":"297","author":"Lee","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2017.01.010_bib41","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.2337\/db12-1464","article-title":"Microphthalmia transcription factor regulates pancreatic \u03b2-cell function","volume":"62","author":"Mazur","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2017.01.010_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000243811","article-title":"Genome-wide analysis of histone H3 lysine 4 trimethylation in peripheral blood mononuclear cells of minimal change nephritic syndrome patients","volume":"30","author":"Zhang","year":"2009","journal-title":"Am J Nephrol"}],"updated-by":[{"DOI":"10.1016\/j.kint.2017.11.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000}}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817300376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817300376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T02:52:53Z","timestamp":1625107973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253817300376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0085253817300376"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.01.010","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}